Tolerogenic Nanoparticles to Treat Islet Autoimmunity
Sign Up to like & getrecommendations! Published in 2017 at "Current Diabetes Reports"
DOI: 10.1007/s11892-017-0914-z
Abstract: Purpose of ReviewThe current standard therapy for type 1 diabetes (T1D) is insulin replacement. Autoimmune diseases are typically treated with broad immunosuppression, but this has multiple disadvantages. Induction of antigen-specific tolerance is preferable. The application… read more here.
Keywords: islet autoimmunity; nanoparticles treat; tolerogenic nanoparticles; tolerance ... See more keywords